We invest in early stage healthcare technology companies
developing solutions for some of the greatest challenges in healthcare, such as mental health, chronic conditions and extending health span
Chronic Conditions
Since we are living longer, we are more likely to develop a chronic condition during our lifetime (and probably die from it) so we invest in the prediction, prevention and management of these conditions
People are living longer but not necessarily living better. We focus our investments on companies promoting healthy aging.
Longevity
Mental Health
Mental health is an integral part of healthcare and there is no good clinical outcome without taking a holistic approach of the patient, so we invest in companies improving mental and brain health
We believe in companies that have a holistic view of patient care and promote prevention, better access, better care or better value
Global reach with a focus in the Americas
presence in Palo Alto,
New York and São Paulo
We leverage our expertise to invest early and generate better returns to our investors
No spraying and praying
A more targeted portfolio allows us to better support our invested companies
Close but not too close
We assist and advise our founders when they need us
Referral network
We leverage our contacts to better support our founders
Scientific and clinical validation
Our partners assist our portfolio companies with a roadmap to design health studies that will inform the research, verification and methodologies in real-world data analysis
IKJ Health Innovation I
.png)
IKJ Health Innovation II
Meet the team
More than 100 years of combined experience in healthcare, investment and management
20+ years of Investment Banking experience,
former Partner and Managing Director at BR Partners
Enrico also held Investment Banking and Capital Markets positions at Credit Suisse,
Merrill Lynch and Santander
Board member of
Cariuma and Mevo
Enrico Carbone
General Partner at IKJ and W250
(Stanford Alumni fund)
15+ years of Investment Banking experience,
former Director at Merrill Lynch’s Investment Banking Division
Fabiana also held Investment Banking positions at Santander and UBS
Fabiana Barruffini
Partner at IKJ Health Innovation
10+ years of Investment Banking experience.
Former interim CFO of
Mevo and Partner and Senior Associate at BR Partners’ Investment Banking division, with extensive experience in M&A and Capital Raising transactions.
Vítor Figueiredo
Partner at IKJ Health Innovation
Visiting professor at
Stanford University in
Palo Alto and was a Visiting Scholar at MIT and Harvard
She uses her clinical and research experience to add value to innovative healthcare startups and help build the tools to improve clinical decision-making and efficiency
Camila Maciel
Venture Partner
MD and very
accomplished
business executive having led numerous Healthcare companies including Fleury, Odontoprev and DaVita in Brazil
He also serves on the boards of Aché, 3778, Humana Magna and Sou Smile.
Mauro Figueiredo
Venture Partner
General Manager
at Carbon Health.
Previously co-founder and CEO at Prairie Health.
Holds a BS in Bioengineering and MS in Computer Science from Stanford.
Maurice Chiang
Venture Partner
Currently is a
Venture Partner
and Investment Advisor in several Silicon Valley VC funds and is on the Board of Revyz.
Has entrepreneurial roots as a founder/CEO of Zephyr, a venture-backed enterprise software company, which he led to a successful exit.
Samir Shah
Venture Partner
IKJ News
Follow us on LinkedIn
for more news
